118 related articles for article (PubMed ID: 18756438)
21. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
22. Relationship of frequency of CD4+CD25+Foxp3+ regulatory T cells with disease progression in antiretroviral-naive HIV-1 infected Chinese.
Zhang Z; Jiang Y; Zhang M; Shi W; Liu J; Han X; Wang Y; Jin X; Shang H
Jpn J Infect Dis; 2008 Sep; 61(5):391-2. PubMed ID: 18806350
[TBL] [Abstract][Full Text] [Related]
23. Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants.
Hesseling AC; Cotton MF; Fordham von Reyn C; Graham SM; Gie RP; Hussey GD
Int J Tuberc Lung Dis; 2008 Dec; 12(12):1376-9. PubMed ID: 19017445
[TBL] [Abstract][Full Text] [Related]
24. A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children.
Steele AD; Cunliffe N; Tumbo J; Madhi SA; De Vos B; Bouckenooghe A
J Infect Dis; 2009 Nov; 200 Suppl 1():S57-62. PubMed ID: 19817615
[TBL] [Abstract][Full Text] [Related]
25. Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy.
Gaardbo JC; Nielsen SD; Vedel SJ; Ersbøll AK; Harritshøj L; Ryder LP; Nielsen JO; Kolte L
Clin Exp Immunol; 2008 Oct; 154(1):80-6. PubMed ID: 18821942
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi.
Helfand RF; Witte D; Fowlkes A; Garcia P; Yang C; Fudzulani R; Walls L; Bae S; Strebel P; Broadhead R; Bellini WJ; Cutts F
J Infect Dis; 2008 Nov; 198(10):1457-65. PubMed ID: 18828743
[TBL] [Abstract][Full Text] [Related]
27. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
Fausther-Bovendo H; Sol-Foulon N; Candotti D; Agut H; Schwartz O; Debré P; Vieillard V
AIDS; 2009 Jun; 23(9):1077-87. PubMed ID: 19424050
[TBL] [Abstract][Full Text] [Related]
28. Cross-sectional study on vaccination coverage in newly diagnosed HIV-infected persons in the Czech Republic.
Jilich D; Malý M; Fleischhans L; Kulířová V; Machala L
Cent Eur J Public Health; 2019 Sep; 27(3):217-222. PubMed ID: 31580557
[TBL] [Abstract][Full Text] [Related]
29. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America.
Aberg JA; Kaplan JE; Libman H; Emmanuel P; Anderson JR; Stone VE; Oleske JM; Currier JS; Gallant JE;
Clin Infect Dis; 2009 Sep; 49(5):651-81. PubMed ID: 19640227
[TBL] [Abstract][Full Text] [Related]
30. The frequency, activation, and coreceptor expression of lymphocytes in human immunodeficiency virus/hepatitis C virus co-infected patients in China.
Shi W; Zhang Z; Zhang M; Liu J; Jiang Y; Wang Y; Jin X; Han X; Shang H
Jpn J Infect Dis; 2009 Jul; 62(4):284-8. PubMed ID: 19628906
[TBL] [Abstract][Full Text] [Related]
31. Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination.
Madhi SA; Klugman KP; Kuwanda L; Cutland C; Käyhty H; Adrian P
J Infect Dis; 2009 Apr; 199(8):1168-76. PubMed ID: 19265481
[TBL] [Abstract][Full Text] [Related]
32. Rates of HIV immune escape and reversion: implications for vaccination.
Davenport MP; Loh L; Petravic J; Kent SJ
Trends Microbiol; 2008 Dec; 16(12):561-6. PubMed ID: 18964018
[TBL] [Abstract][Full Text] [Related]
33. High frequency and proliferation of CD4+ FOXP3+ Treg in HIV-1-infected patients with low CD4 counts.
Bi X; Suzuki Y; Gatanaga H; Oka S
Eur J Immunol; 2009 Jan; 39(1):301-9. PubMed ID: 19089812
[TBL] [Abstract][Full Text] [Related]
34. Treatment of spondylodiscitis in human immunodeficiency virus-infected patients: a comparison of conservative and operative therapy.
Sobottke R; Zarghooni K; Krengel M; Delank S; Seifert H; Fätkenheuer G; Ernestus I; Källicke T; Frangen T; Arasteh K; Oette M; Eysel P
Spine (Phila Pa 1976); 2009 Jun; 34(13):E452-8. PubMed ID: 19478647
[TBL] [Abstract][Full Text] [Related]
35. Progressive CD127 down-regulation correlates with increased apoptosis of CD8 T cells during chronic HIV-1 infection.
Zhang SY; Zhang Z; Fu JL; Kang FB; Xu XS; Nie WM; Zhou CB; Zhao M; Wang FS
Eur J Immunol; 2009 May; 39(5):1425-34. PubMed ID: 19350559
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998--2003.
Teshale EH; Hanson D; Flannery B; Phares C; Wolfe M; Schuchat A; Sullivan P
Vaccine; 2008 Oct; 26(46):5830-4. PubMed ID: 18786586
[TBL] [Abstract][Full Text] [Related]
37. Vaccination in the immunocompromised child: a probe of immune reconstitution.
Abzug MJ
Pediatr Infect Dis J; 2009 Mar; 28(3):233-6. PubMed ID: 19252428
[No Abstract] [Full Text] [Related]
38. [HIV vaccination].
Jablonowski H
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():68-9. PubMed ID: 19031568
[No Abstract] [Full Text] [Related]
39. CD4 validation for the World Health Organization classification and clinical staging of HIV/AIDS in a developing country.
Edathodu J; Ali B; Alrajhi AA
Int J Infect Dis; 2009 Mar; 13(2):243-6. PubMed ID: 18945632
[TBL] [Abstract][Full Text] [Related]
40. [Vaccinations. Immunologic basis, indications, efficacy, complications].
Beytout J
Rev Prat; 2003 Sep; 53(14):1595-604. PubMed ID: 15185669
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]